Docetaxel with epirubicin as first line chemotherapy in metastatic breast cancer (MBC).: Final results of a Phase II study

被引：0

作者：

Morales, S

Lorenzo, A

Ramos, M

Ballesteros, P

Méndez, M

Almanza, C

Moreno-Nogueira, J

Casal, J

Castellanos, J

Lizón, J

机构：

[1] H Arnau de Vilanova, Lleida, Spain

[2] H Puerta Real, Cadiz, Spain

[3] Ctr Oncol Galicia, La Coruna, Spain

[4] H Inmaculada, Almeria, Spain

[5] H Mostoles, Madrid, Spain

[6] Clin Povisa, Vigo, Spain

[7] H Meixoeiro, Vigo, Spain

[8] CH Xeral Cies, Vigo, Spain

[9] H St Joan, Alicante, Spain

来源：

关键词：

D O I：

10.1016/S0959-8049(02)80203-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

117

引用

页码：S68 / S68

页数：1